Antiplasmodial activity of ferrocenyl chalcones: Investigations into the role of ferrocene

European Journal of Pharmaceutical Sciences

Volumn 27, Issue 2-3, 2006, Pages 175-187

  Wu, Xiang ^a   Tiekink, Edward R T ^a   Kostetski, Iouri ^a   Kocherginsky, Nikolai ^a   Tan, Agnes L C ^a   Khoo, Soo Beng ^a   Wilairat, Prapon ^a   Go, Mei Lin ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antiplasmodial activity; Ferrocenyl chalcones; QSAR analysis; Redox properties of ferrocene

Indexed keywords

1 (3 PYRIDINYL) 3 FERROCENYLPROP 2 EN 1 ONE; 1 FERROCENYL 3 (4 NITROPHENYL)PROP 2 EN 1 ONE; CHALCONE DERIVATIVE; FERROCENE; FREE RADICAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ANTIPLASMODIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; HUMAN; HUMAN CELL; LIPOPHILICITY; NONHUMAN; OXIDATION REDUCTION REACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIMALARIALS; CELL LINE, TUMOR; CHALCONES; CRYSTALLOGRAPHY, X-RAY; DOGS; FERROUS COMPOUNDS; FREE RADICALS; HUMANS; MODELS, MOLECULAR; PLASMODIUM FALCIPARUM; PRINCIPAL COMPONENT ANALYSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 29344432675     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2005.09.007     Document Type: Article

References (35)

1. M.C. Alley, D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, R.H. Shoemaker, and M.R. Boyd Feasibility of drug screening with panels of human tumour cell lines using a microculture tetrazolium assay Cancer Res. 48 1988 589 601
2. J.Y. Aston, and A.J. Fry Substituent effects on the reduction potentials of benzalacetophenones (chalcones). Improved substituent constants for such correlations Electrochem. Acta 49 2004 455 459
3. C. Atteke, J.M.M. Ndong, A. Aubouy, L. Maciejewski, J. Brocard, J. Lebibi, and P. Deloron In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon J. Antimicrob. Chemother. 51 2003 1021 1024
4. P. Beagley, M.A.L. Blackie, K. Chibale, C. Clarkson, R. Meijboom, J.R. Moss, P.J. Smith, and H. Su Synthesis and antiplasmodial activity in vitro of new ferrocene-chloroquine analogues Dalton Trans. 2003 3046 3051
5. P.T. Beurskens, G. Admiraal, G. Beurskens, W.P. Bosman, S. García-Granda, J.M.M. Smits, and C. Smykalla The DIRDIF Program System, Technical report of the Crystallography Laboratory 1992 University of Nijmegen
6. R. Blessing An empirical correction for absorption anisotropy Acta Crystallogr., Sect. A 51 1995 33 38
7. C. Biot, L. Delhaes, L. Maciejewski, M. Mortuaire, D. Camus, D. Dive, and J.S. Brocard Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents Eur. J. Med. Chem. 35 2000 707 714
8. K. Chibale, J.R. Moss, M. Blackie, D. van Schalkwyk, and P.J. Smith New amine and urea analogs of ferrochloroquine: synthesis, antimalarial activity in vitro and electrochemical studies Tetrahedral Lett. 41 2000 6231 6235
9. P. Chim, P. Lim, R. Sem, S. Nhem, L. Maciejewski, and T. Fandeur The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum Ann. Trop. Med. Parasitol. 98 2004 419 424
10. L. Delhaes, H. Abessolo, C. Biot, L. Berry, P. Delcourt, L. Maciejewski, J. Brocard, D. Camus, and D. Dive In vitro and in vivo antimalarial activity of ferrocene-chloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites Parasitol. Res. 87 2001 239 244
11. L. Delhaes, C. Biot, L. Berry, L. Maciejewski, D. Camus, J.S. Brocard, and D. Dive Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX Bioorg. Med. Chem. 8 2000 2739 2745
12. J.R. Dimmock, N.M. Kandepu, M. Hetherington, J. Wilson Quail, U. Pugazhenti, A.M. Sudom, M. Chamankhah, P. Rose, E. Pass, T.M. Allen, S. Halleran, E. De Clercq, and J. Balzarini Cytotoxic activities of Mannich bases of chalcones and related compounds J. Med. Chem. 41 1998 1014 1026
13. J.R. Dimmock, G.A. Zello, E.O. Oloo, J. Wilson Quail, H. Kraatz, P. Perjesi, F. Aradi, K. Takacs-Novak, T.M. Allen, C.L. Santos, J. Balzarini, E. De Clercq, and J.P. Stables Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography J. Med. Chem. 45 2001 3103 3111
14. O. Domarle, G. Blampain, H. Agnaniet, T. Nzadiyabi, J. Lebibi, J. Brocard, L. Maciejewski, C. Biot, A.J. Georges, and P. Millet In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine Antimicrob. Agents Chemother. 42 1998 540 544
15. M. Hocek, P. Stepnicka, J. Ludvik, I. Cisarova, I. Votruba, D. Reha, and P. Hobza Ferrocene-modified purines as potential electrochemical markers: synthesis, crystal structures, electrochemistry and cytostatic activity of (ferrocenylethynyl-) and (ferroenylethyl) purines Chem. Eur. J. 10 2004 2058 2066
16. T. Itoh, S. Shirakami, N. Ishida, Y. Yamashita, T. Yoshida, H.S. Kim, and Y. Wataya Synthesis of novel ferrocenyl sugars and their antimalarial activities Bioorg. Med. Chem. Lett. 10 2000 1657 1659
17. H.W. Leung, D.W. Hallesy, L.D. Shott, F.J. Murray, and D.J. Paustenbach Toxicological evaluation of substituted dicylopentadienyliron (ferrocene) compounds Toxicol. Lett. 38 1987 103 108
18. R. Li, G.L. Kenyon, F.E. Cohen, X. Chen, B. Gong, J.N. Dominguez, E. Davidson, G. Kurban, R.E. Miller, E.O. Nuzum, P.J. Rosenthal, and J.H. McKerrow In vitro antimalarial activity of chalcones and their derivatives J. Med. Chem. 38 1995 5031 5037
19. M. Liu, P. Wilairat, and M.L. Go Antimalarial alkoxylated and hydroxylated chalcones: structure activity relationship analysis J. Med. Chem. 44 2001 4443 4452
20. D. Livingstone Data Analysis for Chemists 1995 Oxford University Press Oxford
21. S.N. Lopez, M.V. Castelli, S.A. Zacchino, J.N. Dominguez, G. Lobo, J. Charris-Charris, J.C.G. Cortes, J.C. Ribas, C. Devia, A.M. Rodriguez, and R.D. Enriz In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues with inhibitory properties against polymers of the fungal cell wall Bioorg. Med. Chem. 9 2001 1999 2013
22. S.F. Nielsen, A. Kharazmi, and S.B. Christensen Modification of the α,β-double bond in chalcones only marginally affect the antiprotozoal activities Bioorg. Med. Chem. 6 1998 937 945
23. K.J. Nikula, J.D. Sun, E.B. Barr, W.E. Bechtold, P.J. Haley, J.M. Benson, A.F. Eidson, D.G. Burt, A.R. Dahl, and R.F. Henderson Thirteen-week repeated inhalation exposure of F344/N rats and B6C3F1 mice to ferrocene Fund. Appl. Toxicol. 21 1993 127 139
24. C.W. Ong, J.Y. Jeng, S.S. Juang, and C.F. Chen A ferrocene-intercalator conjugate with a potent cytotoxicity Bioorg. Med. Chem. Lett. 2 1992 929 932
25. D. Osella, M. Ferrali, P. Zanello, F. Laschi, M. Fontani, C. Nervi, and G. Cavigiolio On the mechanism of the antitumour activity of ferrocenium derivatives Inorg. Chim. Acta 306 2000 42 48
26. G. Rastelli, L. Antolini, S. Benvenuti, and L. Costantino Structural bases for the inhibition of aldose reductase by phenolic compounds Bioorg. Med. Chem. 8 2000 1151 1158
27. R. Re, N. Pellergrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans Antioxidant activity applying an improved ABTS radical cation decolorization assay Free Radical Biol. Med. 26 1999 1231 1237
28. G.M. Sheldrick SHELXL97 Program for the Refinement of Crystal Structures 1997 University of Göttingen
29. R.M. Silverstein, and F.X. Webster Spectrometric Identification of Organic Compounds 1997 John Wiley & Sons New York
30. J.C. Swarts, D.M. Swarts, D.M. Maree, E.W. Neuse, C. La Madeleine, and J. Van Lier Polyaspartamides as water-soluble drug carriers. Part 1. Antineoplastic activity of ferrocene-containing polyaspartamide conjugates Anticancer Res. 21 2001 2033 2038
31. A. Tomasi, and A. Iannone ESR Spin trapping artifacts in biological systems L.J. Berliner R. Jacques Biological Magnetic Resonance, EMR of Paramagnetic Molecules Vol13 1993 Plenum Press New York 353 384
32. S. Top, A. Vessieres, C. Cabestaing, I. Laios, G. Leclercq, C. Provot, and G.J. Jaouen Organomet. Chem. 637-639 2001 500 506
33. S. Top, A. Vessieres, G. Leclercq, J. Quivy, J. Tang, J. Vaissermann, M. Huche, and G. Jaouen Synthesis, biochemical properties and molecular modeling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroferrocifens. Evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines Chem. Eur. J. 9 2003 5223 5236
34. X. Wu, P. Wilairat, and M.L. Go Antimalarial activity of ferrocenyl chalcones Bioorg. Med. Chem. Lett. 12 2002 2299 2302
35. R.A. Yeary Chronic toxicity of cyclopentadienyliron (ferrocene) in dogs Toxicol. Appl. Pharmacol. 15 1969 666 676